SynCore Biotechnology Co.,Ltd - Laporan Laba Rugi (TTM)

SynCore Biotechnology Co.,Ltd
TW ˙ TPEX
NT$ 37.00 ↓ -0.35 (-0.94%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi SynCore Biotechnology Co.,Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 10 13 13 12 10 7 9 11 14 16 16 18 19 20 21 23 23 23 24 25
Change (%) 36.11 -5.77 -3.04 -20.12 -28.71 29.53 18.26 28.26 16.31 2.16 9.94 7.31 5.68 3.34 12.25 -2.12 1.77 4.32 3.01
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 6 7 7 6 5 4 5 5 6 7 7 8 8 20 20 21 21 10 11 10
Change (%) 23.14 -6.77 -4.62 -16.97 -24.75 19.52 15.47 11.48 10.85 2.92 8.45 5.73 146.21 -0.82 8.75 -0.32 -50.60 5.41 -4.73
% of Revenue 59.23 53.58 53.01 52.15 54.21 57.21 52.79 51.55 44.80 42.70 43.02 42.44 41.81 97.42 93.50 90.59 92.25 44.78 45.25 41.85
Gross Operating Profit 4 6 6 6 4 3 4 5 8 9 9 10 11 1 1 2 2 13 13 15
Change (%) 54.94 -4.60 -1.25 -23.56 -33.39 42.91 21.38 46.12 20.74 1.58 11.06 8.48 -95.31 160.46 62.49 -19.46 625.62 3.44 9.41
% of Revenue 40.77 46.42 46.99 47.85 45.79 42.79 47.21 48.45 55.20 57.30 56.98 57.56 58.19 2.58 6.50 9.41 7.75 55.22 54.75 58.15
SG&A 40 39 38 38 38 39 42 43 43 43 41 42 42 42 41 42 42 42 44 43
Change (%) -3.20 -1.65 1.06 -0.80 1.43 7.47 2.87 0.32 1.16 -4.88 1.07 -0.07 1.11 -1.43 1.04 0.61 0.38 3.05 -2.05
% of Revenue 407.21 289.60 302.24 315.03 391.22 556.56 461.76 401.69 314.19 273.24 254.42 233.89 217.81 208.39 198.78 178.93 183.92 181.40 179.20 170.40
R&D 375 363 352 325 444 423 391 348 155 157 141 127 130 4 -5 -16 -30 28 27 26
Change (%) -3.04 -3.05 -7.58 36.57 -4.83 -7.55 -11.01 -55.40 1.31 -10.37 -10.02 2.86 -96.98 -228.24 214.24 90.62 -193.60 -5.65 -1.61
% of Revenue 3,823.32 2,723.56 2,801.96 2,670.87 4,566.37 6,095.52 4,350.57 3,273.84 1,138.36 991.56 869.93 712.01 682.46 19.49 -24.19 -67.73 -131.90 121.31 109.71 104.79
OpEx 420 409 397 370 488 466 437 396 204 207 189 176 180 66 56 47 33 81 81 80
Change (%) -2.70 -2.99 -6.70 31.77 -4.56 -6.07 -9.41 -48.47 1.57 -8.79 -6.92 2.29 -63.51 -14.84 -15.51 -30.02 145.13 0.32 -2.27
% of Revenue 4,289.75 3,066.74 3,157.21 3,038.04 5,011.79 6,709.30 4,865.12 3,727.08 1,497.34 1,307.50 1,167.37 988.33 942.08 325.30 268.08 201.79 144.27 347.49 334.15 317.03
Operating Income -411 -396 -384 -358 -478 -459 -428 -386 -190 -191 -173 -158 -161 -46 -35 -24 -10 -58 -57 -54
Change (%) -3.62 -2.89 -6.82 33.54 -4.07 -6.61 -9.99 -50.59 0.51 -9.70 -8.50 1.72 -71.73 -22.91 -32.02 -57.43 468.91 -1.30 -4.52
% of Revenue -4,189.75 -2,966.74 -3,057.21 -2,938.04 -4,911.79 -6,609.30 -4,765.12 -3,627.08 -1,397.34 -1,207.50 -1,067.37 -888.33 -842.08 -225.30 -168.08 -101.79 -44.27 -247.49 -234.15 -217.03
Interest Expense -3 -3 -3 -3 -2 -2 -2 -2 -2 -2 -2 -2 -1 -1 -0 -0 -0 -0 -0 -0
Change (%) 7.02 1.27 -22.13 -12.58 -12.81 -13.02 10.73 9.69 5.63 -6.52 -11.59 -28.93 -41.23 -38.01 -55.76 14.42 22.76 1.32 -14.38
% of Revenue -32.29 -25.39 -27.29 -21.91 -23.98 -29.33 -19.69 -18.44 -15.77 -14.32 -13.11 -10.54 -6.98 -3.88 -2.33 -0.92 -1.07 -1.29 -1.26 -1.04
Net Income -409 -399 -386 -364 -481 -459 -429 -375 -187 -189 -170 -163 -162 -38 -28 -15 0 -54 -55 -53
Change (%) -2.35 -3.25 -5.57 32.01 -4.68 -6.37 -12.64 -50.13 0.86 -9.77 -4.45 -0.69 -76.37 -27.65 -46.71 -102.47 -15,012.91 0.52 -3.31
% of Revenue -4,169.52 -2,991.29 -3,071.15 -2,991.03 -4,943.18 -6,608.98 -4,777.46 -3,529.27 -1,372.14 -1,189.80 -1,050.85 -913.31 -845.21 -189.01 -132.33 -62.83 1.59 -232.60 -224.14 -210.38

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista